Evidence map›Paper›PMID 23070010›Full record

ReviewExperimental oncology2012

Cytometry of apoptosis. Historical perspective and new advances.

D Wlodkowic, J Skommer, Z Darzynkiewicz

Open access · greenAbstract readReview
In one paragraph

Review in Experimental oncology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Comparison of cytotoxicity methods for studyingCentral-European journal of immunology · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. TheFrontiers in microbiology · 2020
    Article
  15. Cancers · 2019
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Changes ofOxidative medicine and cellular longevity · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

D WlodkowicThe BioMEMS Research Group, School of Chemical Sciences, University of Auckland, Auckland, New Zealand. d.wlodkowic@auckland.ac.nz
J Skommer
Z Darzynkiewicz
University of Auckland · NZ

Funding

PROBES FOR FLOW CYTOMETRYR01CA028704 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI DARZYNKIEWICZ, ZBIGNIEW · 1985 to 2014
$6.0M
FACSAria II Cell SorterS10RR026548 · NCRR · NEW YORK MEDICAL COLLEGE · PI DARZYNKIEWICZ, ZBIGNIEW · 2010 to 2010
$500k
NCI NIH HHS R01 CA028704NCRR NIH HHS S10 RR026548PHS HHS NCI RO1 28 704
6 · The paper itself

Abstract

Characteristic changes in cell morphology paralleled by the appearance of a multitude of molecular and biochemical markers occur during apoptosis. These changes vary depending on the cell type, mechanism of induction of apoptosis, and the time-window at which the process of apoptosis is analyzed. By virtue of the capability of rapid measurement of individual cells the flow- and imaging-cytometry become preferred technologies to detect, identify and record incidence of apoptosis in large cell populations. It also provided a valuable tool to investigate molecular mechanisms in field of necrobiology. This review outlines the progress in development of the most commonly used cytometric methods probing cells death based on analysis of fragmentation of DNA, activation of caspases, analysis of mitochondrial potential, alterations in plasma membrane structure and other features that characterize programmed cell death. This article is part of a Special Issue entitled "Apoptosis: Four Decades Later"

Indexed as

ApoptosisChromatinMembrane Potential, MitochondrialAnnexin A5CaspasesDNA FragmentationFlow CytometryFluorescent DyesHumansAnnexin A5CaspasesChromatinFluorescent Dyes

Identifiers

PMID23070010
PMCPMC3476471
OpenAlexW1599553061

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.